Thursday, 30 January 2014

Oramed Announces Successful FDA Phase 2a Clinical Trial Results 

A Phase 2a clinical trial for ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes met all primary and secondary endpoints (Oramed)

Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies

These data indicate that several strategies prevent T2DM, making it possible to make a choice for the individual subject (Diabetes, Obesity and Metabolism)

Lifecourse: management of type 1 diabetes

Management strategies must be tailored to the individual with their age and life circumstances taken into account. Provision of education for patients and their support network is crucial, and should be a priority - includes supplementary audio (The Lancet Diabetes & Endocrinology)

No comments:

Post a Comment